Bulent Bozdogan
Overview
Explore the profile of Bulent Bozdogan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
1093
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Manohar P, Madurantakam Royam M, Loh B, Bozdogan B, Nachimuthu R, Leptihn S
ACS Infect Dis
. 2022 Jan;
8(1):59-65.
PMID: 34979073
Non-antibiotic alternative treatments to combat the increasing number of infections caused by multidrug resistant bacteria are urgently needed. In recent years, bacteriophages have reemerged to potentially replace or complement the...
12.
Hosbul T, Gul-Yurtsever S, Guney-Kaya K, Oryasin E, Bozdogan B
Clin Lab
. 2021 Nov;
67(11).
PMID: 34758212
Background: Coagulase-negative staphylococci (CoNS) are one of the most important causes of infections. Unlike Staphylococcus aureus, less is known about their pathogenic mechanisms. In the present study, we aimed to...
13.
Hosbul T, Aydogan C, Kaya S, Levent B, Turkmen Albayrak H, Sahiner F, et al.
Mikrobiyol Bul
. 2021 Oct;
55(4):480-491.
PMID: 34666650
Increasing resistance to first-line antibiotics used in the treatment of infections caused by Salmonella and Shigella species is emerging. Azithromycin presents a good alternative treatment option for Salmonella and Shigella...
14.
Hosbul T, Guney-Kaya K, Guney M, Sakarya S, Bozdogan B, Oryasin E
Clin Lab
. 2021 Sep;
67(9).
PMID: 34542958
Background: The determination of clonal interactions between microorganisms is very important in epidemiological studies. In the present study, we aimed to evaluate the resistance mechanisms and genetic relationships of carbapenem...
15.
Nachimuthu R, Kannan V, Bozdogan B, Krishnakumar V, S K, Manohar P
Access Microbiol
. 2021 Jun;
3(3):000142.
PMID: 34151148
Clinical pathogens, especially Gram-negative bacteria developing resistance to third-generation cephalosporins, are making clinical outcomes more complicated and serious. This study was undertaken to evaluate the distribution of CTX-M-type extended-spectrum β-lactamases...
16.
Ertabaklar H, Malatyali E, Ozun Ozbay E, Yildiz I, Sinecen M, Ertug S, et al.
Iran J Parasitol
. 2021 Mar;
16(1):81-90.
PMID: 33786050
Background: The present study aimed to determine genetic diversity of isolates with microsatellite markers in Turkey (Nov 2015 to 2016) and to create a web-based microsatellite typing (MT) approach for...
17.
Shanthini T, Manohar P, Samna S, Srividya R, Bozdogan B, Rameshpathy M, et al.
Access Microbiol
. 2020 Sep;
1(3):e000024.
PMID: 32974517
Wastewater has become a potential habitat for multi-drug-resistant bacteria. The present study aims to screen for the presence of carbapenem-resistant bacteria in sewage water samples collected from hospital and non-hospital...
18.
Bayraktar B, Gunduz A, Oryasin E, Erdemir D, Teke L, Aktas E, et al.
Balkan Med J
. 2020 Sep;
38(1):23-28.
PMID: 32921626
Background: Although Methicillin resistant Staphylococcus aureus (MRSA) is one of the major pathogens of healthcare associated infections, we had only sporadic cases in our intensive care unit (ICU) for years....
19.
Gun M, Bozdogan B, Coban A
Future Microbiol
. 2020 Aug;
15:937-944.
PMID: 32762449
Tuberculosis (TB) is one of the oldest health problems in the world and it remains unresolved. Multidrug-resistant-TB and extensively resistant-TB are a serious problem for control programs. The evaluation of...
20.
Malatyali E, Guclu O, Yildiz I, Bozdogan B, Ertug S, Ertabaklar H
Infect Genet Evol
. 2020 Jul;
84:104459.
PMID: 32681998
Trichomonas vaginalis, a flagellated protozoan parasite, is among the most common sexually transmitted pathogens in the world. The present study aimed to identify the genetic profiles of T. vaginalis in...